EudraPharm
EudraPharm, or the European Union Drug Regulating Authorities Pharmaceutical Database, serves as the centralized database for medicinal products that have received authorization within the European Union. Its comprehensive collection incorporates critical information related to the Summary of Product Characteristics, patient or user package leaflets, and data exhibited on the medicinal labelling.
Overview
The primary objective of the EudraPharm database is to provide transparent and accessible data to the public. In order to ensure the information is both beneficial and easily understood by all users, the database is constructed in a manner that is both comprehensive and user-friendly.
Regulatory Framework
The establishment and functioning of EudraPharm are rooted in EU Regulation 726/2004. This regulation outlines the procedures and criteria for granting medicinal product licenses within the European Union, and it mandates the maintenance of an accessible database of authorized products.
Content and Scope
EudraPharm's focus is largely on products that have undergone the Centralised procedure for licensing. This means that for human medicines, EudraPharm primarily acts as a revamped interface, presenting information previously available via the EPARs (European Public Assessment Reports) section at the European Medicines Agency (EMEA).
Accessibility and Usage
EudraPharm is open to the general public, ensuring that individuals, healthcare professionals, researchers, and policymakers can readily access information about authorized medicinal products within the EU. Given its transparency and comprehensiveness, it plays an integral role in promoting informed decisions related to medicinal usage and policy formulation.
See Also
- European Union
- European Medicines Agency (EMEA)
- Medicinal product licensing
- European Medicines Agency
- EUDRANET
- EudraCT
- EudraGMP
- EudraVigilance
External links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
